G. BAŞARAN Et Al. , "The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
BAŞARAN, G. Et Al. 2011. The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15 .
BAŞARAN, G., Saglam, S., Tansan, S., Demirel, M., Gokmen, E., Aktan, S., ... Goker, E.(2011). The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients. JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
BAŞARAN, Gül Et Al. "The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients," JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
BAŞARAN, Gül Et Al. "The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15, 2011
BAŞARAN, G. Et Al. (2011) . "The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients." JOURNAL OF CLINICAL ONCOLOGY , vol.29, no.15.
@article{article, author={Gül BAŞARAN Et Al. }, title={The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2011}